Research Site — Calgary, Alberta

Public research footprint of Research Site, compiled from the ClinicalTrials.gov public registry.

604

Registered studies

208

Active

Recruiting now

321

Completed

Stopped or withdrawn

Most-studied conditions

Newly Diagnosed Multiple Myeloma (NDMM) · Hematologic Malignancies · Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative… · Homeostatic Iron Regulator Gene-related Hereditary Hemochromatosis

Recently updated registry entries

NCT04924075 — Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL)… (Recruiting)
NCT05939414 — An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation… (Recruiting)
NCT06461897 — A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Research Site?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.